Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression
Balázs Szigeti, Brandon Weiss, Fernando E. Rosas, et al.
Psychological Medicine (2024) Vol. 54, Iss. 8, pp. 1717-1724
Closed Access | Times Cited: 23

Showing 23 citing articles:

Expectancy Effects in Psychedelic Trials
Balázs Szigeti, Boris D. Heifets
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 5, pp. 512-521
Closed Access | Times Cited: 21
Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Psychiatry Research (2024) Vol. 335, pp. 115880-115880
Closed Access | Times Cited: 12
Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder
Brandon Weiss, Leor Roseman, Bruna Giribaldi, et al.
International Journal of Mental Health and Addiction (2024) Vol. 22, Iss. 2, pp. 806-841
Open Access | Times Cited: 11
Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression
Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1096-1110
Open Access | Times Cited: 8
Psychedelics in Psychiatry: Oh, What A Trip!
Gregory A. Fonzo, Charles B. Nemeroff, Ned H. Kalin
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 1-5
Closed Access | Times Cited: 1
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects
Drummond E-Wen McCulloch, Matthias E. Liechti, Kim P. C. Kuypers, et al.
Neuroscience Applied (2024) Vol. 3, pp. 103938-103938
Open Access | Times Cited: 5
Effects of psychedelics in older adults: A prospective cohort study
Hannes Kettner, Leor Roseman, Adam Gazzaley, et al.
American Journal of Geriatric Psychiatry (2024) Vol. 32, Iss. 9, pp. 1047-1059
Closed Access | Times Cited: 4
Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial
Benjamin R. Lewis, John Hendrick, Kevin Byrne, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review
Joshua Liebnau, Felix Betzler, André Kerber
Journal of Psychopharmacology (2025)
Open Access
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
David B. Yaden, Marianna Graziosi, Anna Owen, et al.
Psychedelic Medicine (2025)
Closed Access
Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation
Lukas Bobak, Ian Dorney, Alexsandra Kovacevich, et al.
Journal of Psychoactive Drugs (2025), pp. 1-9
Closed Access
Revisiting the domain of suggestion: A meta-analysis of suggestibility across different contexts
Madeline V. Stein, Afik Faerman, Trevor Thompson, et al.
Personality and Individual Differences (2025) Vol. 241, pp. 113181-113181
Open Access
Trait responsiveness to verbal suggestions predicts nocebo responding: A meta‐analysis
Madeline V. Stein, Monika Heller, Sarah Chapman, et al.
British Journal of Health Psychology (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Validation of the Imperial Psychedelic Predictor Scale
Michael Angyus, Sarah Osborn, Eline Haijen, et al.
(2024)
Open Access | Times Cited: 1
Improvements in well-being following naturalistic psychedelic use and underlying mechanisms of change in older adults: A prospective cohort study
Hannes Kettner, Leor Roseman, Adam Gazzaley, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
An investigation of acute Physiological and Psychological Moderators of Psychedelic-induced Personality Change among Healthy Volunteers
Kate Godfrey, Brandon Weiss, Xinwei Zhang, et al.
Neuroscience Applied (2024), pp. 104092-104092
Open Access | Times Cited: 1
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression
Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, et al.
Journal of Affective Disorders (2024) Vol. 372, pp. 523-532
Closed Access | Times Cited: 1
Low‐dose psilocybin in short‐lasting unilateral neuralgiform headache attacks: results from an open‐label phase Ib ascending dose study
James Rucker, Matthew Butler, Sadie Hambleton, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 10, pp. 1309-1317
Open Access | Times Cited: 1
Treatment Expectancies and Psilocybin vs Escitalopram for Depression
Ethan G. Dutcher, Andrew D. Krystal
JAMA Psychiatry (2024) Vol. 82, Iss. 3, pp. 321-321
Closed Access
Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies
Dan Petrovitch, Sean M. Mitchell, Jason Van Allen, et al.
(2024)
Open Access
"Vine of the Soul": The Potential of Ayahuasca for Reducing Depression, Anxiety, and Stress among Ceremony Participants and the Role of Rumination
Banan Ramarushton
(2024)
Open Access
What should constitute a control condition in psychedelic drug trials?
Luana Colloca, Maurizio Fava
Nature Mental Health (2024)
Closed Access
Allaying the fears: Midomafetamine with therapy is a medicine
David Nutt, Tadeusz Hawrot, Peter Hunt, et al.
Drug Science Policy and Law (2024) Vol. 10
Closed Access
Trait responsiveness to verbal suggestions predicts nocebo responding: A meta-analysis
Madeline V. Stein, Monika Heller, Sarah Chapman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top